Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
ACS Omega|May 31, 2021
Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics SimulationsMingsong Shi, Lun Wang, Penghui Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 9, 2024
pH-Dependent Assembly and Stability of Toll-Like Receptor 3/dsRNA Signaling Complex: Insights from Constant pH Molecular Dynamics and Metadynamics SimulationsPenghui Li, Mingsong Shi, Yibo Wang, et al.
Plos One|April 6, 2019
Purification and biochemical characterization of FrsA protein from Vibrio vulnificus as an esteraseXiaoqin Wang, Zhi-Min Li, Qingyue Li, et al.
Bioorganic Chemistry|December 27, 2021
Degrading FLT3-ITD protein by proteolysis targeting chimera (PROTAC)Yong Chen, Xue Yuan, Minghai Tang, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2021
Design, synthesis, and biological evaluation of novel covalent inhibitors targeting focal adhesion kinaseTao Chen, Yan Liu, Mingsong Shi, et al.
European Journal of Medicinal Chemistry|September 2, 2022
Design, synthesis, and pharmacological evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol analogs as novel glutaminase 1 inhibitorsTao Yang, Yang Tian, Yingxue Yang, et al.
Physical Chemistry Chemical Physics : PCCP|February 14, 2022
The binding mechanism of NHWD-870 to bromodomain-containing protein 4 based on molecular dynamics simulations and free energy calculationMingsong Shi, Jun He, Tiantian Weng, et al.
Lipids in Health and Disease|November 30, 2023
Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatmentJianjun Wang, Yang Xia, Yuan Cao, et al.
International Journal of Pharmaceutics: X|February 9, 2026
A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosageJingjing Zhang, Fanchun Hu, Caiting Deng, et al.
European Journal of Medicinal Chemistry|February 13, 2023
Rational design and appraisal of selective Cdc2-Like kinase 1 (Clk1) inhibitors as novel autophagy inducers for the treatment of acute liver injury (ALI)Tao Yang, Yingxue Yang, Yong Chen, et al.
Pageof 5